4//SEC Filing
AHMED NADIM 4
Accession 0000899243-22-021346
CIK 0001789972other
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 4:33 PM ET
Size
5.2 KB
Accession
0000899243-22-021346
Insider Transaction Report
Form 4
AHMED NADIM
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2022-06-06$12.40/sh+8,090$100,316→ 8,090 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $12.34 to $12.45. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Documents
Issuer
Cullinan Oncology, Inc.
CIK 0001789972
Entity typeother
Related Parties
1- filerCIK 0001731193
Filing Metadata
- Form type
- 4
- Filed
- Jun 6, 8:00 PM ET
- Accepted
- Jun 7, 4:33 PM ET
- Size
- 5.2 KB